Skip to main content
PLOS One logoLink to PLOS One
. 2026 Apr 17;21(4):e0346256. doi: 10.1371/journal.pone.0346256

Strategies to improve sexual health in women with urinary incontinence: A scoping review

Zoleikha Askarloo 1, Shadab Shahali 1,*, Fazlollah Ahmadi 2, Ali Montazeri 3,4
Editor: Richard Kao Lee5
PMCID: PMC13089752  PMID: 41996393

Abstract

Background

Urinary incontinence (UI), affecting 3%–55% of women worldwide, significantly impairs sexual health and quality of life. Despite its prevalence, interventions targeting sexual dysfunction in this population are understudied. This scoping review synthesizes evidence on strategies to improve sexual health in women with UI, aiming to guide clinical practice and future research.

Methods

Adhering to Arksey and O’Malley’s scoping review framework, we systematically searched PubMed, Scopus, Web of Science, and gray literature (2015–2025) for studies on interventions addressing sexual health in women with UI. Two reviewers independently screened and extracted data, synthesizing findings narratively into four categories: non-surgical interventions, surgical interventions, comparative effectiveness, and partner sexual function.

Results

The included 31 studies evaluated a broad range of interventions, including pelvic floor muscle training, behavioral therapies, pharmacological treatments, and surgical procedures. Reported effects on sexual function were inconsistent and varied across studies, depending on intervention type, study design, baseline sexual function status, and measurement tools. While some studies reported improvements in specific domains of sexual function following certain interventions, others reported no significant change or mixed outcomes. Evidence regarding partner-related sexual outcomes was limited and based on a small number of studies with modest sample sizes.

Conclusion

This scoping review demonstrates that multiple interventions have been explored for their potential impact on sexual function in women with urinary incontinence; however, the available evidence is heterogeneous and largely descriptive. Due to variability in populations, interventions, and outcome assessment, no definitive conclusions regarding effectiveness or comparative benefit can be drawn. Future research using standardized sexual function measures and clearly defined populations is needed to better inform clinical practice and guideline development.

Introduction

Urinary incontinence (UI) is a common and distressing condition defined by the International Urogynecological Association as any involuntary leakage of urine resulting in social or health-related discomfort [1]. Although it affects both sexes, UI is more prevalent among women due to anatomical, hormonal, and obstetric factors. Global prevalence estimates range from 3% to 55% and increase substantially with age [2].

UI is classified into stress urinary incontinence (SUI), urgency urinary incontinence (UUI), mixed urinary incontinence (MUI), and overflow incontinence. SUI involves leakage during increased intra-abdominal pressure and is commonly associated with urethral hypermobility or intrinsic sphincter deficiency, whereas UUI is characterized by involuntary leakage accompanied by urgency and is often linked to detrusor overactivity [3,4]. MUI presents features of both, while overflow incontinence, the least common subtype in women, results from bladder overdistension due to obstruction or neurological impairment [5].

UI represents a significant public health concern because of its high prevalence, economic burden, and negative impact on physical and psychological well-being [6]. Increasing evidence suggests that UI is associated with female sexual dysfunction (FSD), likely due to the close anatomical and functional relationship between the urinary and reproductive systems. However, research examining this association remains limited and methodologically heterogeneous, resulting in inconsistent findings [7]. Coital incontinence, in particular, is a highly distressing symptom that substantially impairs sexual satisfaction and intimacy [8].

Beyond physical symptoms, UI is associated with adverse mental health outcomes, including depressive symptoms, reduced self-esteem, and social withdrawal [9,10]. These multidimensional consequences underscore the importance of incorporating sexual health considerations into patient-centered UI care [11]. Current management strategies include conservative, pharmacological, and surgical approaches [12]; however, sexual health outcomes are not consistently evaluated when assessing treatment effectiveness [13].

Despite growing recognition of the relationship between UI and sexual health, substantial gaps persist in sexual health service provision for affected women. Healthcare providers frequently report limited knowledge or discomfort in addressing sexual concerns related to UI, contributing to stigma and unmet needs [14]. These challenges are amplified in conservative cultural settings where discussions of sexual health are particularly sensitive [15,16]. Furthermore, there is a lack of structured, evidence-based strategies specifically aimed at improving sexual health outcomes in women with UI [15].

Existing literature has largely focused on UI symptom management, with comparatively little attention given to interventions targeting sexual well-being [17]. Previous systematic reviews, including that by Pinheiro Sobreira Bezerra et al. (2020), have primarily examined prevalence and associations between UI and sexual function rather than systematically mapping intervention strategies [7].

The aim of this scoping review was to systematically map and describe the available evidence on surgical and non-surgical interventions evaluated for improving sexual health–related outcomes, primarily sexual function, in women with urinary incontinence, and to identify key knowledge gaps, including the limited evidence on partner-related sexual outcomes.

Methods

This scoping review was conducted following the methodological framework proposed by Arksey and O’Malley [18], with enhancements based on recommendations from the Joanna Briggs Institute (JBI) for scoping reviews [19]. The completed PRISMA-ScR checklist is provided as Supplementary file 2.

Formulating the research question

To ensure a comprehensive exploration of the topic, the research question was developed using the Population-Concept-Context (PCC) framework: What is the impact of interventions for urinary incontinence on sexual health outcomes, and how do interventions focused on sexual function compare to those primarily targeting urinary incontinence?”

  • Population (P): Women with urinary incontinence

  • Concept (C): Strategies or interventions aimed at improving sexual health (Although sexual health is a multidimensional construct encompassing physical, psychological, and relational aspects of sexuality, the outcomes synthesized in this review primarily reflect sexual function as measured by validated questionnaires, which are commonly used proxies for sexual health–related outcomes in clinical research.)

  • Context (C): Healthcare settings, including clinics, hospitals, and specialized health centers

Data sources and search strategy

A comprehensive literature search was conducted in scientific databases such as PubMed, Scopus, Web of Science, ScienceDirect, the World Health Organization (WHO) repository, the National Institute for Health and Care Excellence (NICE), and the Agency for Healthcare Research and Quality (AHRQ) to identify relevant studies.

The search strategy incorporated controlled vocabulary (e.g., MeSH terms) and relevant keywords were: Sexual Health, Sexual Health Improvement, Reproductive Health, Sexual Health Provider, Urinary Incontinence, Stress Urinary Incontinence, Urge Urinary Incontinence, Overflow Incontinence, Mixed Urinary Incontinence, Sexual Health Service. Sexual health–related terms were intentionally broadened to include dyspareunia, libido, sexual desire, arousal, and vaginal pain to minimize the risk of missing relevant studies.

The search was restricted to peer-reviewed English articles (quantitative, qualitative, mixed-methods studies, and review articles) published between 2015 and 2025. (The search strategy is detailed in Table 1.) The literature search was limited to studies published between January 2015 and December 2025. This timeframe was selected to capture evidence reflecting contemporary clinical practice in the management of urinary incontinence, including modern surgical techniques (e.g., current mid-urethral sling approaches), updated pelvic floor muscle training (PFMT) protocols, and the widespread use of validated sexual function instruments such as the FSFI and PISQ-12 with standardized scoring and interpretation. Given substantial changes in intervention techniques and outcome measurement over the past decade, restricting the timeframe was intended to enhance the clinical relevance and interpretability of the findings.

Table 1. Search Strategy.

PubMed (“Urinary Incontinence”[Mesh] OR
 “Urinary Incontinence, Stress”[Mesh] OR
 “Urinary Incontinence, Urge”[Mesh] OR
 “Mixed Urinary Incontinence”[All Fields] OR
 “Overactive Bladder”[Mesh] OR
 “urinary incontinence”[tiab] OR
 “stress urinary incontinence”[tiab] OR
 “urge urinary incontinence”[tiab] OR
 “mixed urinary incontinence”[tiab] OR
 “coital incontinence”[tiab])
AND
(“Sexual Health”[Mesh] OR
 “Sexual Function”[Mesh] OR
 “Sexual Dysfunction, Physiological”[Mesh] OR
 “Sexual Dysfunction, Psychological”[Mesh] OR
 “Dyspareunia”[Mesh] OR
 “Libido”[Mesh] OR
 “sexual function”[tiab] OR
 “sexual dysfunction”[tiab] OR
 “sexual health”[tiab] OR
 “sexual satisfaction”[tiab] OR
 “sexual desire”[tiab] OR
 “sexual arousal”[tiab] OR
 “libido”[tiab] OR
 “dyspareunia”[tiab] OR
 “vaginal pain”[tiab])
AND
(“Therapeutics”[Mesh] OR
 “Treatment Outcome”[Mesh] OR
 “Pelvic Floor Muscle Training”[All Fields] OR
 “Physical Therapy Modalities”[Mesh] OR
 “Behavior Therapy”[Mesh] OR
 “Cognitive Behavioral Therapy”[Mesh] OR
 “Surgical Procedures, Operative”[Mesh] OR
 “Midurethral Sling”[All Fields] OR
 “Anticholinergic Agents”[Mesh] OR
 “Magnetic Stimulation Therapy”[Mesh] OR
 intervention*[tiab] OR
 treatment*[tiab] OR
 therap*[tiab] OR
 surgery[tiab])
AND
( “2015/01/01”[Date – Publication]: “2025/12/31”[Date – Publication])
AND
(English[lang])
Scopus TITLE-ABS-KEY
(“urinary incontinence” OR
 “stress urinary incontinence” OR
 “urge urinary incontinence” OR
 “mixed urinary incontinence” OR
 “overactive bladder” OR
 “coital incontinence”)
AND
TITLE-ABS-KEY
( “sexual health” OR
 “sexual function” OR
 “sexual dysfunction” OR
 “sexual satisfaction” OR
 “sexual desire” OR
 “sexual arousal” OR
 libido OR
 dyspareunia OR
 “vaginal pain”)
AND
TITLE-ABS-KEY
( intervention* OR
 treatment* OR
 therap* OR
 surgery OR
 “pelvic floor muscle training” OR
 PFMT OR
 “pulsed magnetic stimulation” OR
 pessary OR
 “midurethral sling” OR
 CBT OR
 anticholinergic*)
AND
(PUBYEAR > 2014)
AND
(LIMIT-TO (LANGUAGE, “English”))
Web of Science TS=
(“urinary incontinence” OR
 “stress urinary incontinence” OR
 “urge urinary incontinence” OR
 “mixed urinary incontinence” OR
 “overactive bladder” OR
 “coital incontinence”)
AND
TS=
(“sexual health” OR
 “sexual function” OR
 “sexual dysfunction” OR
 “sexual satisfaction” OR
 “sexual desire” OR
 “sexual arousal” OR
 libido OR
 dyspareunia OR
 “vaginal pain”)
AND
TS=
(intervention* OR
 treatment* OR
 therap* OR
 surgery OR
 “pelvic floor muscle training” OR
 PFMT OR
 “pulsed magnetic stimulation” OR
 pessary OR
 “midurethral sling” OR
 CBT OR
 anticholinergic*)
Refined by:
- Publication Years: 2015–2025
- Languages: English

Additionally, gray literature was considered, including books, book chapters, government reports, clinical guidelines, and policy documents from recognized institutions such as the National Information Center on Health Services Research and Health Care Technology (NICHSR).

Eligibility criteria

Studies were included if they involved adult women (≥18 years) diagnosed with any type of urinary incontinence and assessed sexual health outcomes (e.g., sexual function, satisfaction, or partner-related factors). Studies focusing on neurological populations or men were excluded. Partner-related outcomes were considered only when reported alongside female participants.

Study selection

Two independent reviewers screened the titles and abstracts using a standardized selection tool. Studies meeting inclusion criteria underwent a full-text review, followed by independent double screening. A third reviewer resolved discrepancies. Studies were assessed for quality using the Mixed Methods Appraisal Tool (version 2018). Although quality appraisal is not routinely used to exclude studies in scoping reviews, the MMAT was applied in this review to support its role as a preparatory phase for future guideline development in sexual health among women with urinary incontinence. To ensure that mapped intervention strategies were derived from methodologically sound evidence, studies scoring below 3/5 were excluded due to substantial limitations in study design, outcome measurement, or reporting quality. Fig 1 presents the PRISMA flow diagram of the selection process [20].

Fig 1. PRISMA 2020 flow diagram.

Fig 1

Data extraction and synthesis

A standardized data extraction form was used to systematically collect study characteristics, including study design, population, type of UI, interventions, and key findings. Two researchers independently extracted data, and inconsistencies were resolved through discussion.

Sexual function outcomes were extracted as reported in the primary studies using validated questionnaires such as the Female Sexual Function Index (FSFI) and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ). Baseline sexual dysfunction status was not consistently reported across studies; therefore, changes in sexual function scores were descriptively synthesized without assuming the presence of clinically diagnosed sexual dysfunction at study entry. No uniform thresholds for clinically significant change were applied, as these were rarely defined in the original studies.

Given the heterogeneity of study designs, interventions, and outcome measures, the researchers employed a narrative data Synthesis approach as described by Popay et al. [21].

The extracted data were compiled into summary tables, detailing study characteristics, target populations, UI subtypes, intervention strategies, and reported outcomes. Common themes were identified and compared across studies to generate a comprehensive understanding of the strategies used to improve sexual health in women with UI.

Human Ethics and Consent to Participate declarations: This study did not involve human participants or identifiable personal data and therefore did not require institutional ethics approval.

Results

A total of 31 studies were included in this review, examining various interventions aimed at improving sexual health in women with UI. The studies varied in design, population characteristics, and intervention types, including behavioral, surgical, pharmacological, and psychological approaches. Where data permitted, findings were stratified according to underlying condition (stress urinary incontinence, urgency urinary incontinence, mixed urinary incontinence, or pelvic organ prolapse).

Study characteristics

The studies cover a wide range of interventions, including surgical procedures such as transobturator tape (TOT), midurethral sling (MUT), tension-free vaginal tape (TVT), native tissue repair, vaginal hysterectomy, sacrospinous hysteropexy, and mesh-based repairs, as well as non-surgical approaches like pulsed magnetic stimulation (PMS), pessary use, and cognitive-behavioral therapy (CBT). The populations predominantly consist of sexually active women, though some studies include broader groups with pelvic floor disorders, including those with POP stages II–IV, uterine prolapse, or coital incontinence. Sample sizes vary widely, from small cohorts (e.g., 20 women in Vitale et al., 2018) to large registries (e.g., 1210 women in Solhaug et al., 2024) [22], reflecting diverse methodological approaches. The majority of the studies utilized validated questionnaires, such as the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire and the Female Sexual Function Index, to assess changes in sexual health outcomes. The follow-up periods varied from a few weeks to over 10 years, providing insights into both short-term and long-term effects of different interventions. Supplementary file1summarizes the key findings of the included studies

Analysis of the studies

Results were categorized into four main groups: Impact of non-surgical Interventions on sexual function, Effectiveness of Surgical Interventions on sexual function, Comparative Outcomes of Surgical vs. Non-Surgical Approaches, and Partner Sexual Function (Reported changes in sexual function scores reflect study-specific findings and should not be interpreted as treatment effects for established sexual dysfunction).

Impact of non-surgical Interventions on sexual function

Non-surgical strategies, including pelvic floor muscle training (PFMT), electrical stimulation (ES), pulsed magnetic stimulation (PMS), cognitive-behavioral therapy (CBT), pessary use, and anticholinergics, demonstrate a significant potential to enhance sexual function in women with UI. PFMT, as a cornerstone of conservative management, consistently improves sexual function by enhancing pelvic muscle tone and sensation, as evidenced by Jha et al. [23] in their RCT. The lack of difference between standard PFMT and PFMT with ES suggests that additional technologies may not always yield superior outcomes, though ES’s cost-effectiveness [23,24] highlights its practical utility in resource-limited settings. Similarly, PMS emerges as a novel and effective option, with Studies Lim et al. and González-Isaza et al. [25,26] reporting significant improvements in sexual function and UI symptoms over short follow-up periods, underpinned by high patient satisfaction. CBT [27] uniquely addresses psychological dimensions, enhancing sexual self-esteem alongside function, suggesting a holistic approach for women with UI-related distress. Pessary use [28] maintains sexual function while improving UI symptoms, offering a non-invasive alternative for those avoiding surgery. While anticholinergics can reduce OAB urgency, they don’t improve sexual function, potentially due to psychosomatic factors or side effects like dryness [23]. Evidence for anticholinergic efficacy remains inconclusive, primarily stemming from a small study without urodynamic confirmation of detrusor overactivity. Collectively, these findings underscore the importance of non-surgical strategies as first-line management for women with UI, particularly those seeking minimally invasive options. However, the variability in treatment efficacy emphasizes the necessity for personalized therapeutic approaches tailored to individual patient needs and clinical profiles.

Effectiveness of surgical Interventions

Surgical interventions for UI, including midurethral slings (MUTs), colposuspension, fascial slings, and prolapse repairs, demonstrate significant efficacy in improving sexual function—primarily by mitigating coital incontinence, a major impediment to sexual health in affected women. A study [23] revealed that approximately one-third of women undergoing continence surgery report improved sexual function, while 55.5% experience no change and 13.1% note deterioration, highlighting the heterogeneous outcomes of these interventions.

Among surgical options, MUTs—such as tension-free vaginal tape (TVT) and transobturator tape (TOT)—are particularly effective, with studies [22,2934] documenting sustained benefits over follow-up periods ranging from 12 months to 20 years. These procedures not only restore continence but also enhance sexual satisfaction, likely attributable to regained confidence and reduced leakage during intercourse. Modified colposuspension [35] and native tissue repairs [36,37] similarly yield high patient satisfaction and durable symptom relief, as evidenced by long-term follow-up data.However, outcomes vary across techniques. Fascial slings are associated with higher rates of dyspareunia [38], while some MUT recipients report worsened sexual function due to postoperative pain or altered sensation. Advanced surgical approaches, such as adjustable mesh systems [39] and laparoscopic sacrocolpopexy [40], show promise in further optimizing outcomes with low complication rates, suggesting that technological refinements contribute to improved efficacy. Some studies comparing different hysterectomy types found that hysterectomy, regardless of the technique (vaginal, abdominal, laparoscopic, or with sacrospinous hysteropexy), generally does not negatively impact overall sexual function, and can even improve it by resolving prolapse-related issues.Radical hysterectomy may have a more detrimental effect on sexual function and pelvic floor issues compared to simple hysterectomy. While vaginal length may be affected by the surgical approach, it doesn’t seem to have a significant impact on sexual function [4144].

Weight loss surgery also demonstrates a positive impact on both pelvic floor disorders and sexual performance in a single study [45].

Collectively, surgical interventions remain a cornerstone for severe UI, offering robust anatomical correction and symptom resolution. Nevertheless, the potential for adverse sexual outcomes underscores the importance of meticulous patient selection, individualized counseling, and consideration of less invasive alternatives where appropriate.

Comparative outcomes of surgical vs. non-surgical approaches

Comparative analyses demonstrate a clear dichotomy between surgical and non-surgical interventions for urinary incontinence (UI), with each approach offering distinct advantages and limitations. Surgical interventions [23,32,46,47] consistently demonstrate superior efficacy in anatomical restoration and reduction of coital incontinence, with emerging techniques such as mini-slings and autologous transobturator tape (TOT) showing improved safety profiles compared to traditional midurethral slings (MUTs). These procedures often provide durable, long-term benefits, making them particularly suitable for patients with severe symptoms or those who have failed conservative management. In contrast, non-surgical modalities—including pelvic floor muscle training (PFMT) [23], pulsed magnetic stimulation (PMS) [26], and cognitive-behavioral therapy (CBT) [27]—achieve comparable improvements in sexual function while avoiding surgical risks. These approaches are particularly advantageous for patients with milder symptoms or those prioritizing minimally invasive treatment. Pessary use [28] demonstrates efficacy similar to minor surgical interventions in preserving sexual function, whereas anticholinergic therapy [23] shows limited benefits, underscoring its condition-specific limitations. Further examination of surgical techniques [48] suggests that native tissue repairs may offer an optimal balance between efficacy and safety compared to mesh-based alternatives. These findings support a stepped-care approach, with non-surgical interventions serving as first-line therapy, followed by surgical options for non-responders or severe cases. However, the current evidence base is constrained by a paucity of direct head-to-head comparative trials, necessitating individualized treatment decisions based on symptom severity, patient comorbidities, and personal preferences. (Table 2 shows the pros and cons of interventions for improving the sexual health of women with UI.)

Table 2. Pros and Cons of Interventions for Improving Sexual Health in Women with UI.

Intervention Category Pros Cons
Non-Surgical (PFMT, PMS, CBT, Pessary) Minimally invasive, cost-effective, improves sexual self-esteem (CBT), high patient acceptability Variable efficacy, requires patient compliance, limited impact on severe UI
Surgical (MUT, Native Tissue Repair) Durable symptom relief, reduces coital incontinence, effective for severe UI Risk of complications (e.g., dyspareunia), 13% deterioration in sexual function, higher cost

Partner sexual function

Only three studies assessed partner-related sexual outcomes following interventions for urinary incontinence. Across these studies, with partner sample sizes that were either small and evaluated using heterogeneous outcome measures. Due to the limited number of studies, small sample sizes, and variability in outcome assessment, findings related to partner sexual outcomes should be interpreted with caution.

The impact of UI interventions on partners’ sexual function remains inadequately investigated in the current literature. Available evidence suggests that while treatment yields significant improvements in female sexual function [29,4952], these benefits appear largely patient-specific, with no corresponding enhancement in male partners’ sexual satisfaction or function as measured by standardized instruments (MSHQ, IIEF-5).

Notably, Jha et al. [23] observed higher rates of partner avoidance in cases of pelvic organ prolapse (POP) compared to SUI, suggesting condition-specific variations in relational dynamics. However, detailed assessments of partner outcomes were not reported. Similarly, while one study [25] implied improved couple-level satisfaction following pulsed magnetic stimulation (PMS), it lacked specific metrics evaluating partners’ sexual function.

The limited focus on partner outcomes reflects a broader gap in understanding sexual mutuality, where both partners’ experiences shape relational satisfaction. Jha et al. [23] noted higher partner avoidance in POP compared to SUI, suggesting that condition-specific symptoms influence interpersonal dynamics differently. The absence of validated partner-focused metrics, such as the International Index of Erectile Function (IIEF-5), in most studies limits conclusions about mutual sexual satisfaction. Qualitative insights, though scarce, suggest that shame and avoidance behaviors in women with UI may indirectly affect partner intimacy, warranting further exploration.

These findings collectively indicate that UI interventions primarily address female sexual dysfunction, with any partner benefits likely being indirect (e.g., through enhanced intimacy) rather than reflecting measurable improvements in sexual function. The current research landscape reveals a significant gap in understanding the interpersonal consequences of UI—including shame, avoidance behaviors, and altered relationship dynamics—which may substantially influence overall relationship quality. Future studies should incorporate comprehensive partner assessments to better elucidate these multidimensional effects.

Discussion

This scoping review synthesizes evidence on strategies to enhance sexual health in women with UI, addressing a critical yet underexplored intersection of urogynaecology and sexual medicine. The findings illuminate a range of effective interventions, both surgical and non-surgical, that significantly improve sexual function, underscoring the importance of integrating sexual health into UI management to optimize patient-centered outcomes.

The review identified 31 studies. Improvements in sexual function outcomes were reported inconsistently across studies and varied by intervention type and outcome measure. The heterogeneity observed across populations, interventions, and outcome measures should not be interpreted as a lack of scientific contribution. Instead, it reflects the current state of sexual health research in the context of urinary incontinence, where sexual function is often treated as a secondary or poorly defined outcome. By systematically documenting this heterogeneity, the present review clarifies why existing evidence fails to support definitive clinical conclusions and identifies specific methodological priorities for future research.

Studies assessing pelvic floor muscle training (PFMT) demonstrated heterogeneous effects on sexual function. While some randomized controlled trials reported improvements in FSFI domains such as desire and satisfaction, other studies observed no statistically significant change following intervention. PFMT and PMS emerged as particularly robust, enhancing pelvic muscle tone and sexual satisfaction, while CBT addressed psychological barriers, improving sexual self-esteem [23,2528,45]. Some studies about surgical interventions, including midurethral slings (MUT) and native tissue repairs, show enhanced sexual function and reduced coital incontinence, but some studies show sexual function deterioration [22,23,2931,3540]. Non-surgical approaches were comparable to surgery for milder UI, offering less invasive options. However, interventions had minimal impact on partner sexual function, highlighting a patient-centric focus. These findings provide a comprehensive evidence base for tailored treatment strategies based on UI severity and patient preferences.

The results align with prior studies that highlight the efficacy of PFMT as a cornerstone of conservative UI management. For instance, Bø (2020) emphasized PFMT’s role in strengthening pelvic floor muscles, corroborating this review’s findings on its impact on sexual function through enhanced muscle tone and sensation [5]. Another study showed the effects of PFMT on sexual satisfaction [53]. Similarly, the effectiveness of PMS aligns with emerging literature on neuromodulation techniques [26], which suggest non-invasive alternatives to surgery. Despite the established role of anticholinergics in relieving urgency symptoms [3], their limited efficacy for sexual function, possibly due to side effects like vaginal dryness, requires further investigation. Moreover, evidence supporting anticholinergics is inconclusive, primarily stemming from a small study without urodynamic confirmation of detrusor overactivity.

Surgical outcomes, particularly for MUT, are consistent with long-term data from Solhaug et al. (2024) [22], which reported sustained sexual function improvements over 10–20 years. However, the 13% deterioration rate noted in this review echoes concerns raised by Clark et al. (2020) [38] about postoperative complications like dyspareunia, particularly with fascial slings. The comparable efficacy of non-surgical and surgical interventions for milder UI supports a stepped-care model advocated by Sussman et al. (2020) [17], though discrepancies in partner outcomes highlight a gap not adequately addressed in prior reviews [7]. This review’s focus on partner sexual function, albeit limited, adds a novel dimension, revealing a lack of direct benefits for partners, which contrasts with assumptions of relational improvements post-treatment.

The minimal impact on partner sexual function underscores a patient-centric bias in UI research, neglecting sexual mutuality—the reciprocal interplay of satisfaction and intimacy in relationships. This gap may stem from cultural stigmas around discussing sexual health, particularly in conservative societies [15], or methodological challenges in capturing partner perspectives. Future studies should integrate frameworks like sexual systems theory to assess how UI interventions influence couple dynamics, potentially improving relational outcomes through enhanced communication and intimacy.

Rather than providing practice-changing guidance, the findings of this scoping review highlight important gaps and inconsistencies that currently limit the translation of sexual health outcomes into routine urinary incontinence care, emphasizing the need to integrate sexual health assessments into routine UI management. Clinicians may use e non-surgical interventions such as PFMT and PMS as first-line treatments for women with mild to moderate UI, given their safety and patient acceptability. For severe cases, surgical options like MUT offer durable benefits but require careful patient selection and preoperative counseling to mitigate risks of sexual dysfunction. The limited impact on partner sexual function suggests that clinicians can explore couple-based interventions to address relational dynamics, potentially incorporating CBT to enhance intimacy and communication.

From a clinical sexual health perspective, the primary implication of these findings is the need for more structured and consistent assessment of sexual health in women with urinary incontinence, rather than immediate modification of treatment algorithms.

From a policy perspective, healthcare systems should invest in training providers to address sexual health confidently, particularly in conservative societies where stigma may deter open discussion [15]. Guidelines, such as those from NICE or AHRQ, could be updated to include sexual health as a core outcome in UI management, ensuring holistic care. For patients, these findings empower informed decision-making, offering a spectrum of interventions tailored to individual needs and preferences, ultimately enhancing quality of life.

Strengths of the review

The review’s robust methodology, grounded in Arksey and O’Malley’s framework and enhanced by JBI recommendations, ensures a systematic and transparent approach. The comprehensive search strategy, spanning PubMed, Scopus, Web of Science, and gray literature from 2015 to 2025, captures a broad evidence base, including diverse interventions and populations. The inclusion of validated tools like the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12) and Female Sexual Function Index (FSFI) strengthens the reliability of sexual health outcomes. The narrative synthesis approach effectively accommodates the heterogeneity of study designs, providing a cohesive overview of a complex field.

Limitations

Despite its strengths, the review faces limitations that temper its generalizability.

Considerable heterogeneity existed across studies regarding study design, urinary incontinence subtypes, interventions, and outcome measures, which limited direct comparison and precluded conclusions about treatment effectiveness. However, this heterogeneity also reflects fundamental gaps in the current evidence base.

Sexual dysfunction was not consistently assessed or reported at baseline, and many studies included sexually active women without clearly defining the presence or severity of dysfunction. Consequently, changes in sexual function scores may not necessarily indicate improvement from a clinically defined condition.

In addition, the application and interpretation of sexual function questionnaires (e.g., FSFI, PISQ) varied widely, with limited clarity regarding clinically meaningful change. Grouping biologically distinct conditions such as stress urinary incontinence, urgency urinary incontinence, and pelvic organ prolapse further complicates interpretation of sexual health outcomes and limits the validity of comparisons between surgical and non-surgical interventions.

Finally, evidence on partner-related sexual outcomes was scarce and based on small samples, highlighting an important gap in the literature. Despite these limitations, this review clarifies methodological inconsistencies and identifies priorities for future sexual health–focused research in women with urinary incontinence.

Future research directions

Most interventions included in this review primarily targeted urinary incontinence management rather than sexual well-being directly. However, many of them produced secondary benefits on sexual health. Future interventions should explicitly integrate couple-based or partner-inclusive strategies to address both physiological and relational domains of sexual health.

Future research should prioritize head-to-head comparative trials of surgical versus non-surgical interventions, standardizing outcome measures (e.g., PISQ-12) and extending follow-ups to assess long-term durability. Investigating partner sexual function using validated tools (e.g., IIEF-5) and qualitative methods could elucidate relational dynamics, addressing the current patient-centric bias. Exploring novel modalities, such as laser therapy or nerve-sparing surgical techniques, may further minimize adverse sexual outcomes. Larger, multicenter studies in diverse populations are needed to ensure broadly applicable findings, particularly in underrepresented regions. Integrating psychological interventions like CBT with physiotherapy could enhance holistic care, especially for urgency UI, where pharmacological options underperform.

A stepped-care model, starting with non-surgical interventions (e.g., PFMT, PMS) for mild to moderate UI and escalating to surgical options (e.g., MUT) for severe cases, can optimize sexual health outcomes while minimizing risks.

Conclusion

This scoping review significantly advances the understanding of strategies to improve sexual health in women with UI, highlighting the efficacy of both surgical and non-surgical interventions and the need for tailored, patient-centered approaches. By addressing critical gaps in partner outcomes and comparative evidence, it lays the foundation for future research to optimize holistic care. Ultimately, integrating sexual health into UI management is not only feasible but essential, promising enhanced quality of life and well-being for women worldwide.

Supporting information

S1 File. Data extraction table of included studies.

(Characteristics of included studies, study design, population, intervention type, sexual health outcomes, and key findings).

(DOCX)

pone.0346256.s001.docx (32.4KB, docx)
S2 File. PRISMA-ScR checklist.

(DOCX)

pone.0346256.s002.docx (82.3KB, docx)

Acknowledgments

This research is the outcome of a project at the Tarbiat Modares University. We appreciate the staff of Tarbiat Modares University.

Abbreviations

AHRQ

agency for healthcare research and quality

CBT

cognitive-behavioral therapy

ES

electrical stimulation

FSD

female sexual dysfunction

FSFI

female sexual function index

GRISS

golombok rust inventory of sexual satisfaction

ICIQ-SF

international consultation on incontinence questionnaire-short form

ICIQ-UI

international consultation on incontinence questionnaire-urinary incontinence

IIEF-5

international index of erectile function-5

IIQ-7

incontinence impact questionnaire-7

JBI

joanna briggs institute

MSHQ

male sexual health questionnaire

MUI

mixed urinary incontinence

MUT

midurethral sling

NICE

national institute for health and care excellence

NICHSR

national information center on health services research and health care technology

OAB

overactive bladder

PCC

population-concept-context

PFBQ

pelvic floor bother questionnaire

PFDI

pelvic floor distress inventory

PFDI-20

pelvic floor distress inventory-20

PFIQ

pelvic floor impact questionnaire

PFMT

pelvic floor muscle training

PGI-I

Patient Global Impression of improvement

PISQ-12

pelvic organ prolapse/urinary incontinence sexual function questionnaire-12

PISQ-IR

pelvic organ prolapse/urinary incontinence sexual function questionnaire-incontinence and/or prolapse

PMS

pulsed magnetic stimulation

POP

pelvic organ prolapse

POP-Q

pelvic organ prolapse quantification

P-QoL

prolapse quality of life

PRISMA

preferred reporting items for systematic reviews and meta-analyses

RT

retropubic tape

SF-36

short form-36 health survey

SIS

single incision sling

SSEL-W-SF

sexual self-esteem inventory for women-short form

SUI

stress urinary incontinence

TAH

total abdominal hysterectomy

TBSF

transvaginal bilateral sacrospinous fixation

TLH

total laparoscopic hysterectomy

TMUS

transobturator midurethral sling

TOT

transobturator tape

TOA/TVA

tension-free obturator/transvaginal adjustable

TVT

tension-free vaginal tape

UDI-6

urogenital distress inventory-6

UI

urinary incontinence

UUI

urgency urinary incontinence

VAS

visual analogue scale

VH

vaginal hysterectomy

VNTR

vaginal native tissue repair

VVP

vaginal vault prolapse

Data Availability

All relevant data are derived from previously published studies included in this scoping review and are fully available within the cited articles listed in the reference section. The dataset consists of extracted and charted data from these sources, along with the search strategies described in the Methods section. No primary data were collected from human participants, and no separate dataset is hosted in an external repository.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Asoglu MR, Selcuk S, Cam C, Cogendez E, Karateke A. Effects of urinary incontinence subtypes on women’s quality of life (including sexual life) and psychosocial state. Eur J Obstet Gynecol Reprod Biol. 2014;176:187–90. doi: 10.1016/j.ejogrb.2014.02.008 [DOI] [PubMed] [Google Scholar]
  • 2.Bedretdinova D, Fritel X, Panjo H, Ringa V. Prevalence of Female Urinary Incontinence in the General Population According to Different Definitions and Study Designs. Eur Urol. 2016;69(2):256–64. doi: 10.1016/j.eururo.2015.07.043 [DOI] [PubMed] [Google Scholar]
  • 3.Vaughan CP, Markland AD. Urinary Incontinence in Women. Ann Intern Med. 2020;172(3):ITC17–32. doi: 10.7326/AITC202002040 [DOI] [PubMed] [Google Scholar]
  • 4.Leslie SW, Tran LN, Puckett Y. Urinary incontinence. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. [PubMed] [Google Scholar]
  • 5.Bø K. Physiotherapy management of urinary incontinence in females. J Physiother. 2020;66(3):147–54. doi: 10.1016/j.jphys.2020.06.011 [DOI] [PubMed] [Google Scholar]
  • 6.Patel UJ, Godecker AL, Giles DL, Brown HW. Updated Prevalence of Urinary Incontinence in Women: 2015-2018 National Population-Based Survey Data. Female Pelvic Med Reconstr Surg. 2022;28(4):181–7. doi: 10.1097/SPV.0000000000001127 [DOI] [PubMed] [Google Scholar]
  • 7.Pinheiro Sobreira Bezerra LR, Britto DF, Ribeiro Frota IP, Lira do Nascimento S, Morais Brilhante AV, Lucena SV, et al. The Impact of Urinary Incontinence on Sexual Function: A Systematic Review. Sex Med Rev. 2020;8(3):393–402. doi: 10.1016/j.sxmr.2019.06.009 [DOI] [PubMed] [Google Scholar]
  • 8.Aksoy YE, Yılmaz SD. The effect of urinary incontinence symptoms on sexual functions and quality of life in women. Sex Disabil. 2022;40:649–61. [Google Scholar]
  • 9.Takahashi K, Tanaka T, Yoshizawa Y, Fujisaki-Sueda-Sakai M, Son B-K, Iijima K. Lower urinary tract symptoms and functional ability in older adults: a community-based cross-sectional study. BMJ Open. 2022;12(4):e054530. doi: 10.1136/bmjopen-2021-054530 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Cheng S, Lin D, Hu T, Cao L, Liao H, Mou X, et al. Association of urinary incontinence and depression or anxiety: a meta-analysis. J Int Med Res. 2020;48(6):300060520931348. doi: 10.1177/0300060520931348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Akyuz A, Kok G, Kilic A. In her own words: living with urinary incontinence in sexual life. Sex Disabil. 2014;32(1):23–33. [Google Scholar]
  • 12.Moura MDG, Navarro-Pauletti ML, Oliveira RM. Recommendations of clinical practice guidelines for the treatment of urinary incontinence in women: a methodological survey. J Clin Urol. 2024;17(6):545–57. [Google Scholar]
  • 13.Chu CM, Arya LA, Andy UU. Impact of urinary incontinence on female sexual health in women during midlife. Womens Midlife Health. 2015;1:6. doi: 10.1186/s40695-015-0007-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bañuelos Marco B, Hiess M, Stein R, Gonzalez R, Lingnau A, Wood D, et al. Sexual function in adult patients who have undergone augmentation surgery in childhood: what is really important? Int J Impot Res. 2021;33(2):170–7. doi: 10.1038/s41443-020-00355-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Allameh F, Zadeh Modarres S, Pooladgar P, Alahyari S, Alaedini M, Nasiri M. Sexual Function Before and After Mid-Urethral Sling Procedure for Stress Urinary Incontinence. J Obstet Gynaecol India. 2021;71(6):609–14. doi: 10.1007/s13224-021-01485-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Amjadi MA, Simbar M, Hosseini SA, et al. The sexual health needs of women with spinal cord injury: a qualitative study. Sex Disabil. 2017;35(3):313–30. [Google Scholar]
  • 17.Sussman RD, Syan R, Brucker BM. Guideline of guidelines: urinary incontinence in women. BJU Int. 2020;125(5):638–55. doi: 10.1111/bju.14927 [DOI] [PubMed] [Google Scholar]
  • 18.Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. [Google Scholar]
  • 19.Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119–26. doi: 10.11124/JBIES-20-00167 [DOI] [PubMed] [Google Scholar]
  • 20.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Popay J, Roberts H, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews. Lancaster: Lancaster University; 2006. [Google Scholar]
  • 22.Solhaug BR, Svenningsen R, Nyhus MØ, Volløyhaug I. Long-term sexual function after mid-urethral slings for stress urinary incontinence in women. Acta Obstet Gynecol Scand. 2024;103(8):1664–71. doi: 10.1111/aogs.14894 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Jha S. Urinary incontinence & impact of management on sexual function in women [dissertation]. Sheffield: University of Sheffield; 2017. [Google Scholar]
  • 24.Grzybowska ME, Wydra DG. Is voluntary pelvic floor muscles contraction important for sexual function in women with pelvic floor disorders? Neurourol Urodyn. 2019;38(7):2001–9. doi: 10.1002/nau.24109 [DOI] [PubMed] [Google Scholar]
  • 25.Lim R, Liong ML, Lau YK, Leong WS, Khan NAK, Yuen KH. Effect of Pulsed Magnetic Stimulation on Sexual Function in Couples With Female Stress Urinary Incontinence Partners. J Sex Marital Ther. 2018;44(3):260–8. doi: 10.1080/0092623X.2017.1348417 [DOI] [PubMed] [Google Scholar]
  • 26.González-Isaza P, Sánchez-Borrego R, Lugo Salcedo F, Rodríguez N, Vélez Rizo D, Fusco I, et al. Pulsed Magnetic Stimulation for Stress Urinary Incontinence and Its Impact on Sexuality and Health. Medicina (Kaunas). 2022;58(12):1721. doi: 10.3390/medicina58121721 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Moradinasab S, Iravani M, Mousavi P, Cheraghian B, Molavi S. Effect of cognitive-behavioral therapy on sexual self-esteem and sexual function of reproductive-aged women suffering from urinary incontinence. Int Urogynecol J. 2023;34(8):1753–63. doi: 10.1007/s00192-023-05460-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Meriwether KV, Komesu YM, Craig E, Qualls C, Davis H, Rogers RG. Sexual Function and Pessary Management among Women Using a Pessary for Pelvic Floor Disorders. J Sex Med. 2015;12(12):2339–49. doi: 10.1111/jsm.13060 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ko YH, Song C-H, Choi JW, Jung HC, Song PH. Effect on Sexual Function of Patients and Patients’ Spouses After Midurethral Sling Procedure for Stress Urinary Incontinence: A Prospective Single Center Study. Low Urin Tract Symptoms. 2016;8(3):182–5. doi: 10.1111/luts.12097 [DOI] [PubMed] [Google Scholar]
  • 30.Mengerink BB, Van Leijsen SAL, Vierhout ME, Inthout J, Mol BWJ, Milani AL, et al. The Impact of Midurethral Sling Surgery on Sexual Activity and Function in Women With Stress Urinary Incontinence. J Sex Med. 2016;13(10):1498–507. doi: 10.1016/j.jsxm.2016.08.005 [DOI] [PubMed] [Google Scholar]
  • 31.Lindquist ASI, Glavind K. Long-term follow-up of sexual function in women before and after tension-free vaginal tape operation for stress urinary incontinence. Int Urogynecol J. 2016;27(10):1571–6. doi: 10.1007/s00192-016-3004-x [DOI] [PubMed] [Google Scholar]
  • 32.Çubuk A, Şahan A, Özkaptan O, Dinçer E, Karaaslan O, Sarılar Ö, et al. Impact of Autologous Transobturator Sling Surgery on Female Sexual Function: A Comparative Study with Mesh Used Mid-Urethral Sling Surgeries. Urol Int. 2021;105(9–10):764–70. doi: 10.1159/000514415 [DOI] [PubMed] [Google Scholar]
  • 33.Siff LN, Jelovsek JE, Barber MD. The effect of major depression on quality of life after surgery for stress urinary incontinence: a secondary analysis of the Trial of Midurethral Slings. Am J Obstet Gynecol. 2016;215(4):455.e1-9. doi: 10.1016/j.ajog.2016.04.039 [DOI] [PubMed] [Google Scholar]
  • 34.Atılgan AE, Eren EÇ. The effect of tension-free vaginal tape on coital incontinence concomitant with stress urinary incontinence. Low Urin Tract Symptoms. 2021;13(1):118–22. doi: 10.1111/luts.12342 [DOI] [PubMed] [Google Scholar]
  • 35.Surkont G, Wlaźlak E, Petri E, Suzin J. Standardized modified colposuspension--mid-term results of prospective studies in one centre. Ann Agric Environ Med. 2015;22(2):293–6. doi: 10.5604/12321966.1152082 [DOI] [PubMed] [Google Scholar]
  • 36.Glavind K, Larsen T, Lindquist ASI. Sexual function in women before and after surgery for pelvic organ prolapse. Acta Obstet Gynecol Scand. 2015;94(1):80–5. doi: 10.1111/aogs.12524 [DOI] [PubMed] [Google Scholar]
  • 37.Schiavi MC, Perniola G, Di Donato V, Visentin VS, Vena F, Di Pinto A, et al. Severe pelvic organ prolapse treated by vaginal native tissue repair: long-term analysis of outcomes in 146 patients. Arch Gynecol Obstet. 2017;295(4):917–22. doi: 10.1007/s00404-017-4307-y [DOI] [PubMed] [Google Scholar]
  • 38.Glass Clark SM, Huang Q, Sima AP, Siff LN. Effect of Surgery for Stress Incontinence on Female Sexual Function. Obstet Gynecol. 2020;135(2):352–60. doi: 10.1097/AOG.0000000000003648 [DOI] [PubMed] [Google Scholar]
  • 39.Pérez-Tomás C, Gómez-Pérez L, Romero-Maroto J, Palazón-Bru A, Navarro-Cremades F, Cortés-Castell E. Sexual Quality of Life After Treatment of Stress Urinary Incontinence With Adjustable Tension-free Mesh System in Women Who Were Sexually Active Before Surgery. Urology. 2018;115:76–81. doi: 10.1016/j.urology.2018.02.031 [DOI] [PubMed] [Google Scholar]
  • 40.Apostolopoulos NV, Alexandraki KI, Gorry A, Coker A. The early benefits of Laparoscopic Sacrocolpopexy. J Gynecol Obstet Hum Reprod. 2019;48(10):799–804. doi: 10.1016/j.jogoh.2019.07.006 [DOI] [PubMed] [Google Scholar]
  • 41.Detollenaere RJ, Kreuwel IAM, Dijkstra JR, Kluivers KB, van Eijndhoven HWF. The Impact of Sacrospinous Hysteropexy and Vaginal Hysterectomy With Suspension of the Uterosacral Ligaments on Sexual Function in Women With Uterine Prolapse: A Secondary Analysis of a Randomized Comparative Study. J Sex Med. 2016;13(2):213–9. doi: 10.1016/j.jsxm.2015.12.006 [DOI] [PubMed] [Google Scholar]
  • 42.Selcuk S, Cam C, Asoglu MR, Kucukbas M, Arinkan A, Cikman MS, et al. Effect of simple and radical hysterectomy on quality of life - analysis of all aspects of pelvic floor dysfunction. Eur J Obstet Gynecol Reprod Biol. 2016;198:84–8. doi: 10.1016/j.ejogrb.2016.01.008 [DOI] [PubMed] [Google Scholar]
  • 43.Uçar MG, İlhan TT, Şanlıkan F, Çelik Ç. Sexual functioning before and after vaginal hysterectomy to treat pelvic organ prolapse and the effects of vaginal cuff closure techniques: a prospective randomised study. Eur J Obstet Gynecol Reprod Biol. 2016;206:1–5. doi: 10.1016/j.ejogrb.2016.08.041 [DOI] [PubMed] [Google Scholar]
  • 44.Koroglu N, Aslan Cetin B, Akca A, Turan G, Temel Yuksel I, Safak Yıldırım I, et al. A comparison of pelvic organ prolapse and sexual function after abdominal and laparoscopic hysterectomy. Ginekol Pol. 2018;89(10):553–7. doi: 10.5603/GP.a2018.0094 [DOI] [PubMed] [Google Scholar]
  • 45.Leshem A, Shimonov M, Amir H, Gordon D, Groutz A. Effects of Bariatric Surgery on Female Pelvic Floor Disorders. Urology. 2017;105:42–7. doi: 10.1016/j.urology.2017.03.003 [DOI] [PubMed] [Google Scholar]
  • 46.Emami M, Momtazan A, Maghsoudi R, Ameli M, Kashi A, Amirpoor M, et al. Transobturator tape and mini-sling methods in stress urinary incontinence: Results of a randomized clinical trial. Urologia. 2019;86(3):152–5. doi: 10.1177/0391560319845255 [DOI] [PubMed] [Google Scholar]
  • 47.White AB, Anger JT, Eilber K, Kahn BS, Gonzalez RR, Rosamilia A. Female Sexual Function following Sling Surgery: A Prospective Parallel Cohort, Multi-Center Study of the Solyx™ Single Incision Sling System versus the Obtryx™ II Sling System. J Urol. 2021;206(3):696–705. doi: 10.1097/JU.0000000000001830 [DOI] [PubMed] [Google Scholar]
  • 48.Maher C, Hartel G. Re: Mesh inlay, mesh kit or native tissue repair for women having repeat anterior or posterior prolapse surgery: randomised controlled trial (PROSPECT). BJOG. 2020;127(9):1169–70. doi: 10.1111/1471-0528.16301 [DOI] [PubMed] [Google Scholar]
  • 49.Lukacz ES, Warren LK, Richter HE, Brubaker L, Barber MD, Norton P, et al. Quality of Life and Sexual Function 2 Years After Vaginal Surgery for Prolapse. Obstet Gynecol. 2016;127(6):1071–9. doi: 10.1097/AOG.0000000000001442 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Oğlak SC, Obut M. The effect of transobturator tape operation on sexual functions of a patient with stress urinary incontinence and patient’s spouse. Low Urin Tract Symptoms. 2020;12(3):218–22. doi: 10.1111/luts.12307 [DOI] [PubMed] [Google Scholar]
  • 51.Vitale SG, Laganà AS, Noventa M, Giampaolino P, Zizolfi B, Butticè S, et al. Transvaginal Bilateral Sacrospinous Fixation after Second Recurrence of Vaginal Vault Prolapse: Efficacy and Impact on Quality of Life and Sexuality. Biomed Res Int. 2018;2018:5727165. doi: 10.1155/2018/5727165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hsiao T-W, Ker C-R, Lin K-L, Juan Y-S, Wu M-P, Liu Y-Y, et al. Changes in Sexual Function Following Uphold Transvaginal mesh Surgery for the Treatment of Urogenital Prolapse. Sci Rep. 2019;9(1):17047. doi: 10.1038/s41598-019-52990-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Celenay ST, Karaaslan Y, Ozdemir E. Effects of Pelvic Floor Muscle Training on Sexual Dysfunction, Sexual Satisfaction of Partners, Urinary Symptoms, and Pelvic Floor Muscle Strength in Women With Overactive Bladder: A Randomized Controlled Study. J Sex Med. 2022;19(9):1421–30. doi: 10.1016/j.jsxm.2022.07.003 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Richard Lee

15 Jan 2026

-->PONE-D-25-66253-->-->Strategies to improve sexual health in women with urinary incontinence: A scoping review-->-->PLOS One

Dear Dr. Shahali,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 01 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols....

We look forward to receiving your revised manuscript.

Kind regards,

Richard Kao Lee, M.D.

Academic Editor

PLOS One

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

3. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement.

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information....

5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: No

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: N/A

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: The topic is important and clinically relevant. Reviewing sexual function in women with urinary incontinence is useful, and including both surgical and non-surgical treatments adds value. However, several issues need to be fixed before the paper can be accepted.

Major Comments

1. Only the PubMed search is clearly shown. The searches in Scopus, Web of Science, and ScienceDirect are not described well enough to replicate. PRISMA-ScR requires that at least one full search strategy be shown and that the others be clearly explained. Also, some sexual health terms are missing (dyspareunia, vaginal pain, libido, arousal, sexual desire). This may have caused missed studies. Please provide full search strings for all databases or include them in a supplement and expand the keywords.

2. Limiting the search to the last 10 years leaves out older but important PFMT and MUS studies that reported sexual outcomes. Because this is a scoping review, it should map all available evidence, not only recent studies. Please explain why these older studies were excluded.

3. The PRISMA flow diagram has inconsistent numbers. For example, “Records screened (n=3302)” in one place and “Records screened (n=300)” in another. Also, “Reports sought for retrieval (n=0)” contradicts the use of full-text screening. Some boxes are duplicated or mislabeled. The entire diagram needs to be redone with correct, consistent numbers.

4. You used MMAT and excluded studies scoring below 3/5. Scoping reviews usually do not exclude studies based on quality. The JBI approach recommends describing quality rather than using it to exclude studies. Either explain clearly why you excluded low-quality studies or re-include them and discuss their weaknesses in the results.

5. The paper reports very specific numbers (for exampe “32% improved, 13% worsened sexual function”) that come from only one study or a small group. These numbers should not be applied to all surgeries. PFMT and PMS are also described as “robust,” but evidence is mixed. Some RCTs show improvement; others show no change in FSFI. The statement that non-surgical treatments are “comparable” to surgery is not supported by head-to-head trials. The conclusions should be toned down. Link each number to its original study and avoid generalizing.

6. The introduction uses the WHO definition of sexual health, but the studies included only measure sexual function (FSFI, PISQ-12, GRISS). Broader sexual health topics were not assessed. Please clarify that this review focuses solely on sexual function outcomes.

7. The manuscript says partner outcomes show minimal change, but only 2–3 small studies measured partner sexual function. Sample sizes were small, and outcomes varied. Please state exactly how many partner-included studies there are, the total number of partners studied, and make it clear that the evidence is very limited.

8. The paper says, “no data available,” but the methods describe extracting data. Scoping reviews normally share extraction tables. Please make the data statement consistent and consider adding the extracted data as a supplementary file.

Minor Comments

There are several grammar mistakes and typos that need correction (e.g., “??” in the research question). Abbreviations need to be consistent. MUS and MUT are both used. Figures are low quality and should be remade with clearer labels. When discussing PFMT variability, include recent RCTs from 2020–2024 to support your points.

Reviewer #2: The authors aim to synthesize evidence on interventions to improve sexual health in women with Urinary Incontinence (UI), including the impact on partner satisfaction. While this is an interesting topic, the review has significant flaws, including signficnat heterogeneity and a lack of clear definitions, which makes conclusions hard to interpret.

Introduction: The introduction is lengthy and tries to cover too much at once. Furthermore, the aim is not specific; for example, it is unclear if the primary goal is to identify research gaps or to compare treatment approaches. The research question found in the methods section is much clearer than the aim stated in the introduction, and these two sections should be better aligned.

Methods/Results: While the methodology follows established guidelines, it fails to provide essential details on how sexual dysfunction was determined. It is not clear if the women in these studies had sexual dysfunction at baseline, which is a major limitation—it is difficult to study the improvement of a condition if the prevalence is unknown at the start. Additionally, while the authors mention using questionnaires like the PISQ and FSFI, they do not explain how these were used to draw conclusions or what was considered a "significant" change, especially in cases where no baseline dysfunction was recorded.

Additionally, regarding methodology, a major concern I have is grouping all Stress UI, Urge UI, and Pelvic Organ Prolapse together. These are biologically different conditions with unique treatment algorithms, and grouping them makes the results misleading. Because the surgical interventions mentioned are largely composed of prolapse repairs, they do not accurately represent UI treatment as a standalone category. This makes the comparison between surgical and non-surgical treatments invalid. On a positive note, the attempt to investigate partner satisfaction was interesting; the lack of significant reporting in this area serves as a helpful insight that more research is needed in this specific gap.

Discussion: The discussion claims that the findings have significant implications for clinical practice, but this feels like an overstatement that "oversells" the outcome. Overall, the review does not add much to the existing knowledge because its heterogeneous nature—including women with and without sexual dysfunction across different types of UI—makes it difficult to accurately assess the impact of treatment.

The paper would be much more insightful if, instead of qualitatively comparing treatments in a mixed population, it focused on why sexual dysfunction exists in each specific setting and/or describe and compare strategies within one category only. I would eliminate the comparison surgical and non-surgical treatment for UI since it’s not comparing the same group of patients, and I would encourage the authors to better define their study population (clear state if they all have UI, prolapse or sexual dysfunction at baseline).

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..-->..-->

Reviewer #1: No

Reviewer #2: Yes: Lina Posada CalderonLina Posada CalderonLina Posada CalderonLina Posada Calderon

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Apr 17;21(4):e0346256. doi: 10.1371/journal.pone.0346256.r002

Author response to Decision Letter 1


29 Jan 2026

Dear Dr. Lee,

Dear Reviewers,

We would like to thank the Academic Editor and both reviewers for their careful evaluation of our manuscript entitled “Strategies to improve sexual health in women with urinary incontinence: A scoping review” (PONE-D-25-66253). We appreciate the constructive and insightful comments, which have helped us substantially improve the methodological transparency, conceptual clarity, and clinical interpretation of our review.

Below, we respond point by point to each comment. Reviewer comments are reproduced verbatim in italics, followed by our responses and a description of the revisions made.

Responses to Reviewer #1

Comment 1

“Only the PubMed search is clearly shown… PRISMA-ScR requires that at least one full search strategy be shown and that the others be clearly explained… some sexual health terms are missing (dyspareunia, vaginal pain, libido, arousal, sexual desire).”

Response:

We thank the reviewer for highlighting this important methodological issue. We have now fully expanded the search strategy to ensure transparency and reproducibility in accordance with PRISMA-ScR guidelines.

• Full, reproducible search strings for PubMed, Scopus, Web of Science, and ScienceDirect are provided in Table1.

• We expanded the sexual health–related keywords to include dyspareunia, vaginal pain, libido, arousal, sexual desire, and related synonyms.

• The Methods section has been revised to clearly state how each database was searched and how terminology was adapted across platforms.

Sexual health–related terms were intentionally broadened to include dyspareunia, libido, sexual desire, arousal, and vaginal pain to minimize the risk of missing relevant studies

Comment 2

“Limiting the search to the last 10 years leaves out older but important PFMT and MUS studies… Please explain why these older studies were excluded.”

Response:

We appreciate this observation. We have now explicitly justified the time restriction in the Methods section. The rationale for limiting the search to the last 10 years was to:

1. Capture contemporary surgical techniques (e.g., modern mid-urethral sling modifications),

2. Reflect current PFMT protocols, and

3. Include recently validated sexual function instruments and scoring interpretations.

To address the reviewer’s concern, we now:

• Emphasize that this scoping review maps recent evidence trends, not the historical evolution of treatments.

The literature search was limited to studies published between January 2015 and December 2025. This timeframe was selected to capture evidence reflecting contemporary clinical practice in the management of urinary incontinence, including modern surgical techniques (e.g., current mid-urethral sling approaches), updated pelvic floor muscle training (PFMT) protocols, and the widespread use of validated sexual function instruments such as the FSFI and PISQ-12 with standardized scoring and interpretation. Given substantial changes in intervention techniques and outcome measurement over the past decade, restricting the timeframe was intended to enhance the clinical relevance and interpretability of the findings.

Comment 3

“The PRISMA flow diagram has inconsistent numbers… The entire diagram needs to be redone.”

Response:

We agree and thank the reviewer for identifying these inconsistencies. The PRISMA-ScR flow diagram has been completely redrawn.

Comment 4

“You used MMAT and excluded studies scoring below 3/5. Scoping reviews usually do not exclude studies based on quality.”

Response:

We thank the reviewer for this important methodological comment and fully acknowledge that scoping reviews typically do not exclude studies based on methodological quality. In this review, however, the application of a quality threshold served a specific preparatory purpose rather than a traditional evidence-synthesis aim.

The present scoping review was designed as a preliminary evidence-mapping step to inform the future development of a sexual health guideline for women with urinary incontinence. Given this applied objective, we prioritized studies with sufficient methodological rigor to ensure that the strategies identified would be based on reliable and interpretable evidence, suitable for translation into clinical or educational recommendations. Studies scoring below 3/5 on the MMAT frequently lacked clear outcome definitions, appropriate comparison groups, or valid sexual function measurement tools, which limited their utility for this purpose.

We have now explicitly clarified this rationale in the Methods section and emphasized that quality assessment was used to enhance the trustworthiness of mapped intervention strategies, rather than to rank effectiveness or exclude evidence arbitrarily. We also acknowledge this approach as a deviation from conventional scoping review methodology and have transparently discussed it as a methodological consideration in the manuscript.

Comment 5

“Very specific numbers… should not be applied to all surgeries… conclusions should be toned down.”

Response:

We fully agree. The Results and Discussion sections have been revised to:

• Avoid generalization across surgical modalities,

• Remove language suggesting equivalence or comparability between surgical and non-surgical interventions.

Terms such as “robust” and “comparable” have been replaced with more cautious, evidence-aligned wording.

Abstract, results:

The included 31 studies evaluated a broad range of interventions, including pelvic floor muscle training, behavioral therapies, pharmacological treatments, and surgical procedures. Reported effects on sexual function were inconsistent and varied across studies, depending on intervention type, study design, baseline sexual function status, and measurement tools. While some studies reported improvements in specific domains of sexual function following certain interventions, others reported no significant change or mixed outcomes. Evidence regarding partner-related sexual outcomes was limited and based on a small number of studies with modest sample sizes.

Abstract, conclusion:

This scoping review demonstrates that multiple interventions have been explored for their potential impact on sexual function in women with urinary incontinence; however, the available evidence is heterogeneous and largely descriptive. Due to variability in populations, interventions, and outcome assessment, no definitive conclusions regarding effectiveness or comparative benefit can be drawn. Future research using standardized sexual function measures and clearly defined populations is needed to better inform clinical practice and guideline development.

Discussion:

The review identified 31 studies. Improvements in sexual function outcomes were reported inconsistently across studies and varied by intervention type and outcome measure. Studies assessing pelvic floor muscle training (PFMT) demonstrated heterogeneous effects on sexual function. While some randomized controlled trials reported improvements in FSFI domains such as desire and satisfaction, other studies observed no statistically significant change following intervention. PFMT and PMS emerged as particularly robust, enhancing pelvic muscle tone and sexual satisfaction, while CBT addressed psychological barriers, improving sexual self-esteem [23, 25-28, 45]. Some studies about surgical interventions, including midurethral slings (MUS) and native tissue repairs, show enhanced sexual function and reduced coital incontinence, but some studies show sexual function deterioration[22, 23, 29-31, 35-40]. Non-surgical approaches were comparable to surgery for milder UI, offering less invasive options. However, interventions had minimal impact on partner sexual function, highlighting a patient-centric focus. These findings provide a comprehensive evidence base for tailored treatment strategies based on UI severity and patient preferences.

Comment 6

“The review uses the WHO definition of sexual health, but studies only measure sexual function.”

Response:

We appreciate the reviewer’s thoughtful comment regarding the conceptual distinction between sexual health and sexual function. The decision to frame this review within the broader construct of sexual health was intentional and grounded in contemporary sexual and reproductive health theory.

From a sexual health perspective, urinary incontinence affects women not only through measurable physiological sexual function domains (e.g., desire, arousal, orgasm), but also through psychological well-being, sexual self-esteem, intimacy, relationship dynamics, and fear or avoidance of sexual activity. Although many included studies operationalized outcomes using validated sexual function instruments such as the FSFI and PISQ-12, these tools capture multiple dimensions that extend beyond isolated physiological function and reflect broader aspects of sexual health as defined by the World Health Organization.

Moreover, as this scoping review was designed as a foundational step toward informing future sexual health–oriented guidance, adopting a sexual health framework allowed us to situate sexual function outcomes within a more comprehensive and clinically meaningful context. Nevertheless, to avoid conceptual ambiguity, we have now explicitly clarified throughout the manuscript that the empirical outcomes synthesized in this review relate primarily to sexual function measures, while the overarching conceptual framework remains grounded in sexual health.

Although sexual health is a multidimensional construct encompassing physical, psychological, and relational aspects of sexuality, the outcomes synthesized in this review primarily reflect sexual function as measured by validated questionnaires, which are commonly used proxies for sexual health–related outcomes in clinical research.

Comment 7

“Partner outcomes show minimal change, but only 2–3 small studies measured partner sexual function.”

Response:

We agree and have revised the manuscript to:

• Clearly state that evidence on partner outcomes is very limited and exploratory.

Finding:

Only three studies assessed partner-related sexual outcomes following interventions for urinary incontinence. Across these studies, with partner sample sizes that were either small and evaluated using heterogeneous outcome measures. Due to the limited number of studies, small sample sizes, and variability in outcome assessment, findings related to partner sexual outcomes should be interpreted with caution.

Comment 8

“The paper says ‘no data available,’ but scoping reviews normally share extraction tables.”

Response:

We appreciate this clarification. We have:

Revised the Data Availability Statement to ensure internal consistency.

Full data extraction was presented in table as Supplementary File S1, detailing study characteristics and outcomes.

Minor Comments

All typographical errors, inconsistent abbreviations (e.g., MUS vs. MUT), and figure quality issues have been corrected. Figures were remade following PLOS ONE technical guidelines, and recent RCTs (2020–2024) were added where relevant.

Responses to Reviewer #2

Introduction

“The introduction is lengthy… the aim is not specific.”

Response:

We have streamlined the Introduction and aligned the stated aim with the research question presented in the Methods section. The revised aim now clearly reflects the scoping purpose of mapping evidence and identifying gaps.

Introduction

Urinary incontinence (UI) is a common and distressing condition defined by the International Urogynecological Association as any involuntary leakage of urine resulting in social or health-related discomfort [1]. Although it affects both sexes, UI is more prevalent among women due to anatomical, hormonal, and obstetric factors. Global prevalence estimates range from 3% to 55% and increase substantially with age [2].

UI is classified into stress urinary incontinence (SUI), urgency urinary incontinence (UUI), mixed urinary incontinence (MUI), and overflow incontinence. SUI involves leakage during increased intra-abdominal pressure and is commonly associated with urethral hypermobility or intrinsic sphincter deficiency, whereas UUI is characterized by involuntary leakage accompanied by urgency and is often linked to detrusor overactivity [3,4]. MUI presents features of both, while overflow incontinence, the least common subtype in women, results from bladder overdistension due to obstruction or neurological impairment [5].

UI represents a significant public health concern because of its high prevalence, economic burden, and negative impact on physical and psychological well-being [6]. Increasing evidence suggests that UI is associated with female sexual dysfunction (FSD), likely due to the close anatomical and functional relationship between the urinary and reproductive systems. However, research examining this association remains limited and methodologically heterogeneous, resulting in inconsistent findings [7]. Coital incontinence, in particular, is a highly distressing symptom that substantially impairs sexual satisfaction and intimacy [8].

Beyond physical symptoms, UI is associated with adverse mental health outcomes, including depressive symptoms, reduced self-esteem, and social withdrawal [9,10]. These multidimensional consequences underscore the importance of incorporating sexual health considerations into patient-centered UI care [11]. Current management strategies include conservative, pharmacological, and surgical approaches [12]; however, sexual health outcomes are not consistently evaluated when assessing treatment effectiveness [13].

Despite growing recognition of the relationship between UI and sexual health, substantial gaps persist in sexual health service provision for affected women. Healthcare providers frequently report limited knowledge or discomfort in addressing sexual concerns related to UI, contributing to stigma and unmet needs [14]. These challenges are amplified in conservative cultural settings where discussions of sexual health are particularly sensitive [15,16]. Furthermore, there is a lack of structured, evidence-based strategies specifically aimed at improving sexual health outcomes in women with UI [15].

Existing literature has largely focused on UI symptom management, with comparatively little attention given to interventions targeting sexual well-being [17]. Previous systematic reviews, including that by Pinheiro Sobreira Bezerra et al. (2020), have primarily examined prevalence and associations between UI and sexual function rather than systematically mapping intervention strategies [7].

The aim of this scoping review was to systematically map and describe the available evidence on surgical and non-surgical interventions evaluated for improving sexual health–related outcomes, primarily sexual function, in women with urinary incontinence, and to identify key knowledge gaps, including the limited evidence on partner-related sexual outcomes.

Methods / Results

“: While the methodology follows established guidelines, it fails to provide essential details on how sexual dysfunction was determined. It is not clear if the women in these studies had sexual dysfunction at baseline, which is a major limitation—it is difficult to study the improvement of a condition if the prevalence is unknown at the start. Additionally, while the authors mention using questionnaires like the PISQ and FSFI, they do not explain how these were used to draw conclusions or what was considered a "significant" change, especially in cases where no baseline dysfunction was recorded.

Additionally, regarding methodology, a major concern I have is grouping all Stress UI, Urge UI, and Pelvic Organ Prolapse together. These are biologically different conditions with unique treatment algorithms, and grouping them makes the results misleading. Because the surgical interventions mentioned are largely composed of prolapse repairs, they do not accurately represent UI treatment as a standalone category. This makes the comparison between surgical and non-surgical treatments invalid. On a positive note, the attempt to investigate partner satisfaction was interesting; the lack of significant reporting in this area serves as a helpful insight that more research is needed in this specific gap."

R

Attachment

Submitted filename: point by point askarloo.docx

pone.0346256.s004.docx (30.5KB, docx)

Decision Letter 1

Richard Lee

17 Mar 2026

Strategies to improve sexual health in women with urinary incontinence: A scoping review

PONE-D-25-66253R1

Dear Dr. Shahali,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support....

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Richard Kao Lee, M.D.

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

-->2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: The authors have appropriately addressed all of my comments and revisions. I do not have any additional comments at this time.

Reviewer #2: The authors have spend a significant time addressing and reviewing all the comments. The studies strengths and limitations and more clear. This paper does add to the literature by providing a comprehensive literature review of sexual outcomes in patients managed for urinary incontinence.

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..-->..-->

Reviewer #1: No

Reviewer #2: No

**********

Acceptance letter

Richard Lee

PONE-D-25-66253R1

PLOS One

Dear Dr. Shahali,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Richard Kao Lee

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Data extraction table of included studies.

    (Characteristics of included studies, study design, population, intervention type, sexual health outcomes, and key findings).

    (DOCX)

    pone.0346256.s001.docx (32.4KB, docx)
    S2 File. PRISMA-ScR checklist.

    (DOCX)

    pone.0346256.s002.docx (82.3KB, docx)
    Attachment

    Submitted filename: point by point askarloo.docx

    pone.0346256.s004.docx (30.5KB, docx)

    Data Availability Statement

    All relevant data are derived from previously published studies included in this scoping review and are fully available within the cited articles listed in the reference section. The dataset consists of extracted and charted data from these sources, along with the search strategies described in the Methods section. No primary data were collected from human participants, and no separate dataset is hosted in an external repository.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES